Search results

Narrow your search

Result types
Article type
Jurisdiction
Practice area
Industry sector

Showing 2091 - 2100 of 2133 for "Copyright & related rights" with applied filters

News & Analysis

Turkey: New company set to boost IP commercialisation

31 August 2018 by Özge Atilgan Karakulak

Özge Atılgan Karakulak and Güldeniz Doğan Alkan of Gün + Partners examine the advantages and disadvantages of TÜRKSMD, a new company set up by the Turkish IP Office to value intellectual property rights

News & Analysis

Examining the droit moral of integrity

02 July 2018 by Managing Intellectual Property

In Mexico, droit moral is attached to the author and is inalienable, does not expire, cannot be waived and cannot be encumbered. The author and his/her heirs can enforce this right.

News & Analysis

Kenyan authorities propose changes to the ACA and IPA

02 July 2018 by Wayne Meiring

The Kenyan authorities have published a bill, the Statute Law (Miscellaneous Amendments) Bill 2018 (the Bill), which proposes significant changes to two pieces of IP legislation.

News & Analysis

Supreme Court examines patent infringement case concerning the limitation period

02 July 2018 by Managing Intellectual Property

The general limitation period for juridical actions in Austria is 30 years. However, particular laws can stipulate shorter or longer limitation periods.

News & Analysis

IPOPHL proposes amendments to mediation rules

02 July 2018 by Editha Hechanova

All government agencies such as the Intellectual Property Office of the Philippines (IPOPHL) are directed to promote the use of alternative dispute resolution (ADR) in resolving disputes and cases.

News & Analysis

Two different approaches to patent applications: Europe and North America

02 July 2018 by Managing Intellectual Property

CRISPR technology enables genes to be edited and can eventually treat diseases caused by gene mutations.

News & Analysis

Court affirms validity of crestor patent

02 July 2018 by Takanori Abe

Shionogi is the owner of a patent entitled Pyrimidine Derivatives (JP2648897). X filed a request for a trial for invalidation of the patent. Nippon Chemiphar intervened in the trial as a plaintiff, and AstraZeneca UK intervened in the trial in order to support the defendant.

News & Analysis

Registration no longer constitutes legitimate use defence in Turkey

02 July 2018 by Managing Intellectual Property

Turkey has welcomed the new Intellectual Property Code (the IP Code) numbered 6769. This came into force on January 10 2017.

News & Analysis

Court awards compensation to Acteon for nullity proceedings

02 July 2018 by Managing Intellectual Property

In a recent ruling by the Court of The Hague (ECLI:NL:RBDHA:2018:4591) a defendant/patentee has been ordered to pay the costs of nullity proceedings brought against it, despite not wishing to maintain or assert its patent.

News & Analysis

Levi’s wins trade mark claim against Hema

02 July 2018 by Managing Intellectual Property

Denim giant Levi Strauss & Co has recently won a trade mark infringement case against Dutch retail chain Hema concerning its famous V-shaped stitching on the back pockets of its jeans.